Werlinich Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Hold
28,835
1.42% 23
2026
Q1
$3.47M Hold
28,835
1.68% 20
2025
Q4
$3.06M Hold
28,835
1.51% 23
2025
Q3
$2.42M Buy
28,835
+50
+0.2% +$4.12K 1.2% 24
2025
Q2
$2.28M Buy
28,785
+665
+2% +$52.9K 1.24% 23
2025
Q1
$2.52M Buy
28,120
+2,530
+10% +$236K 1.6% 20
2024
Q4
$2.52M Hold
25,590
1.46% 22
2024
Q3
$2.91M Hold
25,590
1.69% 18
2024
Q2
$3.32M Hold
25,590
2.07% 11
2024
Q1
$3.37M Hold
25,590
2.2% 12
2023
Q4
$2.76M Sell
25,590
-429
-2% -$44.5K 2.09% 14
2023
Q3
$2.68M Buy
26,019
+254
+1% +$27.4K 2.21% 15
2023
Q2
$2.97M Hold
25,765
2.39% 12
2023
Q1
$2.74M Sell
25,765
-90
-0.3% -$9.72K 2.41% 15
2022
Q4
$2.87M Hold
25,855
2.65% 12
2022
Q3
$2.23M Hold
25,855
2.28% 16
2022
Q2
$2.36M Sell
25,855
-840
-3% -$74.5K 2.2% 17
2022
Q1
$2.19M Hold
26,695
1.67% 22
2021
Q4
$2.05M Hold
26,695
1.49% 25
2021
Q3
$2.01M Buy
26,695
+1,000
+4% +$76.1K 1.62% 22
2021
Q2
$2M Sell
25,695
-1,233
-5% -$91.7K 1.61% 23
2021
Q1
$1.98M Buy
+26,928
New +$1.99M 1.74% 20

Other funds holding MRK

Werlinich Asset Management's MRK Position: Q2 2026 in Review

Werlinich Asset Management held its Merck (MRK) position steady in Q2 2026 at 28,835 shares worth $3.71M. The position accounts for 1.42% of the portfolio, ranked #23.

Werlinich Asset Management first reported a position in MRK in Q1 2021 and has held it in 22 quarters since. 924 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Werlinich Asset Management held 28,835 shares of Merck worth $3.71M as of Q2 2026.
  • Werlinich Asset Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 1.42% of Werlinich Asset Management's portfolio in Q2 2026, its #23 holding.
  • Werlinich Asset Management first reported a position in Merck in Q1 2021 and has held it in 22 quarters since.
  • 924 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Werlinich Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.